𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid for primary sclerosing cholangitis

✍ Scribed by Chazouillères, Olivier; Poupon, Raoul; Capron, Jean-Pierre; Metman, Etienne-Henry; Dhumeaux, Daniel; Amouretti, Michel; Couzigou, Patrice; Labayle, Denis; Trinchet, Jean-Claude

Book ID
121997104
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
220 KB
Volume
11
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metronidazole and ursodeoxycholic acid f
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial
✍ Martti Färkkilä; Anna-Liisa Karvonen; Heimo Nurmi; Hannu Nuutinen; Matti Taavits 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

No effective medical therapy is currently available for primary sclerosing cholangitis (PSC). Ursodeoxycholic acid (UDCA) improves liver enzymes, but its effect on liver histology is controversial. Metronidazole (MTZ) prevents PSC-like liver damage in animal models and reduces intestinal permeabilit

High-dose ursodeoxycholic acid for the t
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve